Analgesic Drugs Flashcards
Opioid vs opiate
Opioid - acts at opioid receptor
Opiate - derived from opium poppy
Structural classification of opioids
Natural:
Morphine analogues - codeine, morphine
Semi-synthetic
Morphine analogues - diamorphine, dihydrocodeine
Thebaine derivatives - buprenorphine, oxycodone
Synthetic:
Anilinopiperidines - alfentanyl, fentanyl, remi, phenoperidine, sufentany,
Diphenylheptanes - dextropropoxhphene, methadone
Morphinans- levophanol, butorphanol
Phenylpiperdines - pethadine
Types of natural opioids
Phenanthrene (morphine, codiene, thebane - doesn’t do much itself but used for subsequent derivation of oxycodone, naloxone and buprenophine)
Benzylisoquinolines (papaverine, noscopine)
What are the opioid partial agonists and mixed agonist-antagonists?
Effect in patients
Partial - buprenorphine
Mixed - pentazocin, nalbuphine, nalorphine
Provide analgesia in opioid naive but withdrawal in dependant patients
Efficacy of buprenorphine
60-70%
What isomers of opioids exist? Clincial relevance
Opiates - all produced as steriospecific
Synthetic - all racemic
Most cases S are responsible for most clinical effects
Some eg tramadol require both
Rough structure of an opioid and binding
Five rings A-E with A and B in one plane and C and E perpendicular to them
A lies flush to receptor and E fits into a groove in it
Main groups of opioid receptor
MOP - mu
DOP - delta
KOP - kappa
NOP - Orphanin
Effect of MOP receptors
Open potassium channels causing hyperpolarisation and reduced firing
Location of MOP receptors
Primary afferent neurones
Peripheral sensory neurones
Periaquaductal grey matter
Nucleus raphe Magnus
Rostral ventral medulla
Thalamus
Cerebral cortex
Prototype and endogenous agonists at MOP
Prototype - morphine
Natural - leu-enkephalin, met-enkephalin, beta- endorphin
Action at DOP receptors
Potassium channel opening causing hyperpolarisation and decreased neuronal firing
Location of DOP receptors
Olfactory bulb
Cerebral cortex
Primary afferent neurones
Motor integration area
Nociception areas
Prototype and endogenous agonist at DOP
Prototype - ala-leu-enkephalin
Endogenous - leu-enkephalin, met-enkephalin, beta endorphin
Action at KOP receoptors
Directly close calcium channels reducing neurotransmitter release
KOP receptor location
Hypothalamus
Nocicption areas
Prototype and endogenous agonist at KOP
Prototype - ketocyclazocine
Endogenous - dynorphine, beta endorphins
Action of NOP receptors
Directly closing calcium channels reducing neurotransmitter release
Location of NOP receptors
Nucleus raphe Magnus
Primary afferent neurones
Endogenous ligand at NOP
Nociceptin
Orphanin
Structure of an opioid receptor
GPCR
7 transmembrane domains with extracellular n terminus and intracellular c terminus
2nd and 3rd loops responsible for binding.
Have inhibitory action on adenyl cyclase reducing cAMP formation
How do opioid receptors produce stimulatory responses
Inhibition of inhbition
Effect of stimulation of NOP
Clinical implication
Pro nociceptive effect (spinal and supraspinal) or antinociceptive in high concentrations
Thought to be responsible for setting pain thresholds and formation of tolerance.
NOP antagonists produce analgesia and reduce opiate tolerance
MOP and DOP have similar opiate effects all over
What differences do KOP receptors have in their action
Less resp depression
No effect on GI mobility
Dysphoria rather than euphoria
Less sedation or dependence
Cause diuresis